CTLA4 and neoplasm: In one study, a soluble PD-1-based TWIST1 DNA vaccine in conjunction with anti-CTLA-4 antibody significantly reduced tumor growth and lung metastasis, presumably by increasing IFN-γ+ TNFα+ CD8+ T-cells [43].